Annas Al‐Sharea

1.5k total citations
18 papers, 768 citations indexed

About

Annas Al‐Sharea is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Annas Al‐Sharea has authored 18 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Annas Al‐Sharea's work include Immune cells in cancer (5 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Platelet Disorders and Treatments (3 papers). Annas Al‐Sharea is often cited by papers focused on Immune cells in cancer (5 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Platelet Disorders and Treatments (3 papers). Annas Al‐Sharea collaborates with scholars based in Australia, United States and United Kingdom. Annas Al‐Sharea's co-authors include Andrew Murphy, Prabhakara R. Nagareddy, Dragana Dragoljevic, Man K.S. Lee, Jaye Chin‐Dusting, Gerard Pernes, Beatriz Y. Hanaoka, Michelle Flynn, Chander Raman and Gopalkrishna Sreejit and has published in prestigious journals such as Circulation, Diabetes and Scientific Reports.

In The Last Decade

Annas Al‐Sharea

18 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annas Al‐Sharea Australia 13 363 333 170 134 121 18 768
Katia Galan Switzerland 17 300 0.8× 264 0.8× 165 1.0× 136 1.0× 120 1.0× 19 799
Sumra Nazir Germany 9 330 0.9× 167 0.5× 85 0.5× 114 0.9× 93 0.8× 12 715
Carlo Marchetti United States 16 775 2.1× 295 0.9× 237 1.4× 114 0.9× 175 1.4× 27 1.2k
Sunitha Yanamadala United States 17 262 0.7× 232 0.7× 257 1.5× 125 0.9× 92 0.8× 23 879
Christina Grothusen Germany 13 179 0.5× 276 0.8× 304 1.8× 180 1.3× 189 1.6× 53 849
Dickson W.L. Wong Germany 14 254 0.7× 286 0.9× 76 0.4× 50 0.4× 107 0.9× 27 867
Ihsan Gadi Germany 11 334 0.9× 161 0.5× 59 0.3× 107 0.8× 79 0.7× 13 676
Miguel Carracedo Sweden 18 197 0.5× 125 0.4× 165 1.0× 131 1.0× 140 1.2× 24 753
Friedrich Felix Hoyer Germany 14 307 0.8× 274 0.8× 162 1.0× 59 0.4× 48 0.4× 19 814
Kelly L. Davenpeck United States 13 221 0.6× 371 1.1× 146 0.9× 75 0.6× 177 1.5× 16 1.0k

Countries citing papers authored by Annas Al‐Sharea

Since Specialization
Citations

This map shows the geographic impact of Annas Al‐Sharea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annas Al‐Sharea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annas Al‐Sharea more than expected).

Fields of papers citing papers by Annas Al‐Sharea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annas Al‐Sharea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annas Al‐Sharea. The network helps show where Annas Al‐Sharea may publish in the future.

Co-authorship network of co-authors of Annas Al‐Sharea

This figure shows the co-authorship network connecting the top 25 collaborators of Annas Al‐Sharea. A scholar is included among the top collaborators of Annas Al‐Sharea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annas Al‐Sharea. Annas Al‐Sharea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wylie, Robert H., et al.. (2024). Community screening for iron deficiency in reproductive aged women: Lessons learnt from Australia. Vox Sanguinis. 120(1). 22–31. 3 indexed citations
2.
Auerbach, Michael, et al.. (2023). Intravenous Iron Therapy to Treat Anemia in Oncology: A Mapping Review of Randomized Controlled Trials. Current Oncology. 30(9). 7836–7851. 5 indexed citations
3.
Lee, Man K.S., Michael J. Kraakman, Dragana Dragoljevic, et al.. (2021). Apoptotic Ablation of Platelets Reduces Atherosclerosis in Mice With Diabetes. Arteriosclerosis Thrombosis and Vascular Biology. 41(3). 1167–1178. 15 indexed citations
4.
Dragoljevic, Dragana, Camilla Bertuzzo Veiga, Danielle L. Michell, et al.. (2021). A spontaneously hypertensive diet-induced atherosclerosis-prone mouse model of metabolic syndrome. Biomedicine & Pharmacotherapy. 139. 111668–111668. 3 indexed citations
5.
Sreejit, Gopalkrishna, Ahmed Abdel‐Latif, Baskaran Athmanathan, et al.. (2020). Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction. Circulation. 141(13). 1080–1094. 211 indexed citations
6.
Sharma, Arpeeta, Nada Stefanovic, Annas Al‐Sharea, et al.. (2020). Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis. Diabetes. 70(3). 772–787. 115 indexed citations
7.
Lee, Man K.S., Annas Al‐Sharea, Waled Shihata, et al.. (2019). Glycolysis Is Required for LPS-Induced Activation and Adhesion of Human CD14+CD16− Monocytes. Frontiers in Immunology. 10. 2054–2054. 54 indexed citations
8.
Al‐Sharea, Annas, Andrew Murphy, Lesley A. Huggins, et al.. (2018). SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr type 1 diabetic mice. Atherosclerosis. 271. 166–176. 50 indexed citations
9.
Kraakman, Michael J., Hélène L. Kammoun, Dragana Dragoljevic, et al.. (2018). Leptin-deficient obesity prolongs survival in a murine model of myelodysplastic syndrome. Haematologica. 103(4). 597–606. 8 indexed citations
10.
Al‐Sharea, Annas, Man K.S. Lee, Danielle L. Michell, et al.. (2018). Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis. Haematologica. 104(3). 456–467. 49 indexed citations
11.
Dragoljevic, Dragana, Michael J. Kraakman, Prabhakara R. Nagareddy, et al.. (2018). Defective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritis. European Heart Journal. 39(23). 2158–2167. 66 indexed citations
12.
Lee, Man K.S., Annas Al‐Sharea, Dragana Dragoljevic, & Andrew Murphy. (2018). Hand of FATe: lipid metabolism in hematopoietic stem cells. Current Opinion in Lipidology. 29(3). 240–245. 10 indexed citations
13.
Al‐Sharea, Annas, et al.. (2018). The haematopoietic stem cell niche: a new player in cardiovascular disease?. Cardiovascular Research. 115(2). 277–291. 14 indexed citations
14.
Gao, Xiao-Ming, Alan C. Tsai, Annas Al‐Sharea, et al.. (2017). Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture. Cardiovascular Drugs and Therapy. 31(2). 145–156. 30 indexed citations
15.
Al‐Sharea, Annas, et al.. (2017). Nicotinic acetylcholine receptor alpha 7 stimulation dampens splenic myelopoiesis and inhibits atherogenesis in Apoe −/− mice. Atherosclerosis. 265. 47–53. 20 indexed citations
16.
Qin, Cheng Xue, Annas Al‐Sharea, Mitchel Tate, et al.. (2017). Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo. Scientific Reports. 7(1). 16615–16615. 32 indexed citations
17.
Moore, Xiao‐Lei, Fang Lü, Dmitri Sviridov, et al.. (2015). Native LDL promotes differentiation of human monocytes to macrophages with an inflammatory phenotype. Thrombosis and Haemostasis. 115(4). 762–772. 21 indexed citations
18.
Lee, Man K.S., Xiao‐Lei Moore, Yi Fu, et al.. (2015). High‐density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin‐1. British Journal of Pharmacology. 173(4). 741–751. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026